Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer (Q56783598)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

main subject

phase II clinical trial

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Eileen M. O'Reilly

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

David H Ilson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Lawrence H Schwartz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Marinela Capanu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Manish A Shah

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

David P Kelsen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Gary K Schwartz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

13 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

875-880

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00280-008-0677-y

2 January 2020

exact match

0 references

cites work

Bryostatin 1, a novel antineoplastic agent and protein kinase C activator, induces human myalgia and muscle metabolic defects: a 31P magnetic resonance spectroscopic study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00280-008-0677-Y

Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supply

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00280-008-0677-Y

10.1007/S00280-008-0677-Y

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18270704%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference